An interventional study of technology driven self coaching and Health coaching in Pre-obesity and Obesity, sponsored by Slovak Academy of Sciences. Recruiting at 1 site in Slovakia. Open to participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-05-21.
Sponsored by Slovak Academy of Sciences · Not applicable, Interventional, and Health services research
Among 34 studies in Obesity with a site in Slovakia — 9 open to participants now, 17 under way, 14 of them phase 3. Obesity · Slovakia.
Among the 34 studies in Obesity with a site in Slovakia, this one is the 25th largest by planned enrollment, is one of 8 that started in 2025, is one of 6 with no phase, reaches primary completion later than 2 of the 16 other live ones, and was the 22nd registered.
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
This study's planned enrollment of 320 is above the median of 67 across 9,006 interventional studies indexed under Obesity.
Browse Obesity studies →9 of the 34 studies in Obesity with a site in Slovakia are open now, in 12 countries. Each count lists the studies.
Of the 1,336 Obesity studies recruiting now, 377 (28%) set no upper age limit and 856 (64%) stop at 75 or younger; 168 take children under 18; 491 take healthy volunteers.
This study: 25 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →34 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 8 started in 2025.
Median enrollment 632 across the 34 interventional studies. Of the 14 that completed or were terminated, 4 (29%) have results posted.
29 of 34 have an industry lead sponsor. The 10 most frequent:
Slovak Academy of Sciences is the lead sponsor of 13 studies on the registry; 3 are open to participants now.
Slovak Academy of Sciences has 5 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
4 of the studies in Obesity with a site in Slovakia that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07220759Phase 3Novo Nordisk A/SWeight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide | 2027-05-12 |
| NCT07311850Phase 3PfizerEfficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity | 2027-09-21 |
| NCT05556512Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | 2027-10 |
| NCT07400653Phase 3PfizerA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) | 2027-10-12 |
Among the 34 studies in Obesity with a site in Slovakia, from their registry updates:
The principal objective of the project is:
This research project is aimed at leveraging digital tools to personalise preventive healthcare interventions for at-risk populations in ways that address the above-mentioned challenges. At risk populations, in the context of this project, generally means: Younger to middle aged (aged 30-50) sedentary individuals with (pre)obesity expressing behavioural, clinical, biochemical and anamnestic indicators of increased risk for accelerated decline of cardio-metabolic and cognitive health.
Primary outcomes will be the rate of wearable adoption/use, individualised behavioural change persistence and elicited health benefit
Secondary outcomes will include step count, activity of medium \& vigorous intensity, sleep duration/efficiency, heart rate, quality of life, body weight, body composition, blood pressure, and level of fitness as determined by the wearable or validated questionaires available on the landing page.
Participants will be randomly assigned into one of the three intervention groups and a control group. The three intervention groups:
Self-health coaching will be conducted using wearable and technology provided nudges allowing personalised technology-assisted real-time feedback. With this approach, on-line intervention with minimal human resource costs and high technology involvement with a potential to deliver sustainable and cost-effective behavioural change to a large at-risk population will be tested.
This intervention approx. 80 participants will be examined for the duration of 14 weeks. Long term follow up examination is envisaged, but it is beyond this study duration and will be supported by subsequent funding.
Innovative strategies to employ AI and machine learning will be tested to support their meaningful (providing real health benefits) and cost effective use.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Self coaching (technology-assisted online intervention)
Behavioral: technology driven self coaching
Health coaching - online contact with professional coach
Behavioral: Health coaching
Peer coaching - online contact with peer-coach
Behavioral: Peer coaching
Wearable and basic information on healthy lifestyle will be provided, but any of the coaching strategies will be applied
Behavioral: Active Control
subject will be provided with the technology driven lifestyle coaching based on the real time data from the wearables
participants will be provided with the health coach (expert) driven lifestyle coaching based on the real-time data from the wearables
participants will be provided with the peer coach (expert) driven lifestyle coaching based on the real-time data from the wearables
participants will be provided with the wearable, but not exposed to any of the coaching strategies. Real-time data provided by the wearable will be available to them.
Rate of wearable adoption/use
Rate of wearable adoption/use will be determenrd from the wearable allowed data in-flow.
Time frame: 24 months
Effect of intervention on Quality of life
Quality of life will be provided by the validated questionaire filled in at baseline and after completing the study.
Time frame: 24 months
Effect of intervention on health
Effects of intervention for health state will be provided by the questionaire administered at the baseline and after completing the study.
Time frame: 24 months
Habitual physical activity volume
wearable (Garmin vivosmart 5) provided daily step count
Time frame: 24 months
Sleep quality
wearable (Garmin vivosmart 5) provided sleep quality parameter
Time frame: 24 months
Activity-related energy expenditure
Wearable (Garmin - vivosmart 5) provided daily active calories measure.
Time frame: 24 months
Stress level
Wearable (GARMIN vivosmart 5) provided measure of daily stress level
Time frame: 24 months
Plan to share: No — Data will be provided in scientiffic publications. Anz data related to this study could be available upon reasonable request after their publication.
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for May 2026, 12 months after the start.
Of 3,680 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.
Counting every sponsor, half of 3,843 studies reached it within 22 months; a quarter within 10 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Slovak Academy of Sciences